Last updated on March 2019

A Prospective Observational Study to Estimate the Incidence of Febrile Neutropenia (FN) Among Subjects With Non-myeloid Malignancies at High Risk for FN and Receiving Neulasta® (pegfilgrastim) Onpro® kit or Other Physician Choice Options for Prophylaxis of FN

Brief description of study

A clinical trial for those that are at risk for Febrile Neutropenia (FN) and for FN preventative treatment.


Clinical Study Identifier: TX218067

Find a site near you

Start Over

IACT Health

5210 Armour Rd Suite 400 Columbus, GA USA
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.